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Background: Larsen syndrome is an autosomal dominant osteochondrodysplasia characterised by large-joint
dislocations and craniofacial anomalies. Recently, Larsen syndrome was shown to be caused by missense
mutations or small inframe deletions in FLNB, encoding the cytoskeletal protein filamin B. To further delineate
the molecular causes of Larsen syndrome, 20 probands with Larsen syndrome together with their affected
relatives were evaluated for mutations in FLNB and their phenotypes studied.
Methods: Probands were screened for mutations in FLNB using a combination of denaturing high-
performance liquid chromatography, direct sequencing and restriction endonuclease digestion. Clinical and
radiographical features of the patients were evaluated.
Results and discussion: The clinical signs most frequently associated with a FLNB mutation are the presence of
supernumerary carpal and tarsal bones and short, broad, spatulate distal phalanges, particularly of the
thumb. All individuals with Larsen syndrome-associated FLNB mutations are heterozygous for either missense
or small inframe deletions. Three mutations are recurrent, with one mutation, 5071GRA, observed in 6 of 20
subjects. The distribution of mutations within the FLNB gene is non-random, with clusters of mutations leading
to substitutions in the actin-binding domain and filamin repeats 13–17 being the most common cause of
Larsen syndrome. These findings collectively define autosomal dominant Larsen syndrome and demonstrate
clustering of causative mutations in FLNB.
L
arsen syndrome (Online Mendelian Inheritance in Man
(OMIM) 150250) was first described as an entity compris-
ing congenital large-joint dislocations and characteristic
craniofacial abnormalities.1 The cardinal features of the condi-
tion are dislocations of the hip, knee and elbow joints, with
equinovarus or equinovalgus foot deformities. Spatula-shaped
fingers, most marked in the thumb, are also present.
Craniofacial anomalies include hypertelorism, prominence of
the forehead, a depressed nasal bridge and a flattened
midface.1–4 Cleft palate and short stature are often associated
characteristics.1 3 5 6 Spinal anomalies include scoliosis and
cervical kyphosis; cervical kyphosis can be associated with a
myelopathy.6 7 Hearing loss is a well-recognised complication8–10
often caused by malformations of the auditory ossicles.11 12
Supernumerary carpal and tarsal bones (representing second-
ary ossification centres—for example, in the calcaneus)2 13 are a
useful diagnostic feature in early childhood. Intrafamilial
variation in Larsen syndrome is a prominent feature of the
disorder.14 15
There is clear evidence for an autosomal dominant form of
Larsen syndrome, with multiple instances of male-to-male
transmission being described2 11 16 17 in addition to linkage data
that defines a locus at 3p21.1–14.1.17 Instances of sibling
recurrence to unaffected parents have been retrospectively
explained by parental germline mosaicism on subsequent
observation of vertical transmission of the phenotype.18–20
Other instances of sibling recurrence to unaffected parents
may reflect the same underlying mechanism.13 Presentations
consistent with somatic mosaicism have also been reported.9 21
Other conditions labelled as Larsen syndrome or Larsen-like
entities have been described (OMIM 245650), many with a
more severe phenotype including additional extraskeletal
features. Associated malformations include cardiac defects,22–28
laryngotracheomalacia,29–34 brain abnormalities (microcephaly,
pachygyria, colpocephaly, corpus callosum agenesis)29 30 33–35
and inguinal herniae.25 26 29 Some of these phenotypes segre-
gated in a fashion consistent with autosomal recessive
inheritance, prompting some to recognise a recessive form of
Larsen syndrome despite many cases having major phenotypic
dissimilarities with the entity Larsen et al1 initially described.
Many have noted more severe skeletal and extraskeletal
phenotypic features including perinatal lethality in presumptive
recessively inherited cases, implying that it is possible to
clinically distinguish these heterogeneous entities from auto-
somal dominant Larsen syndrome.26 36 However, clear criteria
that definitively delineate recessively inherited forms of Larsen
syndrome from the dominantly inherited entity have not been
established.13 31
Laville et al36 and Bonaventure et al37 described several large
families, from La Re´union Island, which segregated a pheno-
type resembling Larsen syndrome, but with severe short
stature, advanced skeletal maturation, diaphyseal bowing and
lethality in childhood. Recurrence of the phenotype to
unaffected parents in an isolated population firmly implicates
an autosomal recessive mode of inheritance. Other similar
cases have since been reported.28 This clinical presentation has
more similarities to Desbuquois dysplasia than to Larsen
syndrome.37
Abbreviations: FLNA, filamin A gene; FLNA, filamin B gene; MCPP,
metacarpophalangeal pattern; OMIM, on-line mendelian inheritance in
man; OPD, otopalatodigital syndrome
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Clinical similarities between Larsen syndrome and a group of
lethal osteochondrodysplasias including atelosteogenesis types
I (AOI, OMIM 108720) and III (AOIII, OMIM 108721), and
boomerang dysplasia (OMIM 112310) suggested that they
represent an allelic series of conditions.38 39 These more severe
dysplasias are characterised by underossification of skeletal
elements, hypoplastic or absent limb bones, joint dislocations
and craniofacial abnormalities. These observations, with the
phenotypic similarities between Larsen syndrome and otopala-
todigital syndrome type 1 (OPD1), an X-linked skeletal disorder
caused by mutations in FLNA,40 the gene encoding filamin A,
led to the description of mutations in the paralogous gene
filamin B gene (FLNB) underlying Larsen syndrome, AOI, AOIII
and boomerang dysplasia.41 42 Mutations leading to AOI and
AOIII were clustered in calponin homology domain 2 (CH2)
and repeats 13–17.43
Filamin B is a cytoskeletal protein that is important in
modulation of the cellular cytoskeleton and signal transduc-
tion. It is composed of two calponin homology domains at the
N-terminal forming an actin-binding domain, and 24 structu-
rally homologous repeats, separated by two hinge regions
located between repeats 15 and 16, and 23 and 24. Four
missense mutations and one inframe deletion were identified
associated with Larsen syndrome and localised to portions of
the gene encoding the actin-binding domain and repeats 14
and 15. Mutations leading to AOI and AOIII were also clustered
in FLNB, in contrast with nonsense and frameshift mutations
leading to spondylocarpotarsal syndrome, which were more
randomly located throughout the gene.42
In vivo, filamins form dimers, with repeat 24 acting as a
dimerisation domain. The hinge regions confer flexibility on the
filamin dimer structure, enabling orthogonal actin cross-
linking. Several proteins bind to the C-terminal portion of
filamin B. The physiological relevance of filamin binding to
many of these interacting proteins, including integrin b1A and
b1D subunits, presenilins 1 and 2, glycoprotein Iba, filamin-
binding LIM protein 1 and epithin, is unclear,44–48 but emerging
evidence supports a role for filamins in the integration of cell
signalling and cytoskeletal remodelling.49
In this paper a cohort of 20 unrelated families with Larsen
syndrome is reported, comprising 52 affected individuals. We
note the clinical features associated with the presence of a
FLNB mutation and examined for genotype–phenotype correla-
tions for this disorder. Mutations were non-randomly distrib-
uted and some were recurrently observed. In addition, a
characteristic clinical phenotype for Larsen syndrome asso-
ciated with mutations in FLNB was delineated.
METHODS
Patient ascertainment
Patients or families with a diagnosis of Larsen syndrome were
ascertained by doctor-initiated referral. Informed consent was
obtained from participants or their legal guardians. Patients
and family members were examined by their doctor. Clinical
photographs and a full skeletal radiographic survey were
obtained where possible. For some patients, full radiographic
and clinical details were not obtainable. Ethical approval for
this study was obtained from the Otago Ethics Committee.
Molecular analysis
Genomic DNA from cases to be examined was extracted from
whole blood using standard procedures. FLNB exons and exon–
intron boundaries were amplified using polymerase chain
reaction as described previously.42 Primers and polymerase
chain reaction conditions are available on request. Amplified
DNA was subject to denaturing high-performance liquid
chromatography on a WAVE DNA fragment analysis system
(Transgenomic, Omaha, Nebraska, USA) according to the
manufacturer’s instructions. Amplicons showing anomalous
traces were re-amplified and cycle-sequenced on an ABI 3100
sequencer. Where mutations were shown to have arisen de novo,
declared relationships were verified by genotyping both parents
and the patient at six microsatellite loci. Where parental
samples were not available or the trait was familial, the
mutation was shown to be absent in 100 control chromosomes.
Metacarpophalangeal pattern profiles
Metacarpophalangeal pattern (MCPP) profile analyses were
performed as described previously.50 Bone lengths of the 19
individual bones of the hand were measured in millimetres,
expressed in standard deviation (SD) units (z scores) relative to
age-specific and gender-specific mean bone lengths, and
corrected for age, gender and height using ANTRO software
(V.4.83E).50–52 To quantify the altered structure of a hand, a
pattern variability index (sZ) was calculated,
53 which describes
the variance of z scores of an MCPP profile. The mean sZ of the
normal population is approximately 0.5. A sZ value .0.8 (the
95th centile) is considered to be suggestive of a malformation
syndrome.
RESULTS
Clinical presentation
Table 1 shows the clinical descriptions of patients with a FLNB
mutation. There were 8 male and 12 female probands; 16
isolated cases and 4 familial cases. All probands had disloca-
tions or subluxation of the large joints (65% with elbow, 80%
with hip and 80% with knee dislocations). The most mildly
affected proband (case 3) manifested subluxable shoulders as
her only large-joint symptom. Clubfoot was present in 75%.
Anterior thoracic wall deformities (pectus excavatum or pectus
carinatum) were present in 55% of patients. Short stature was
common (14/20 cases recording height below the 10th centile).
Height less than the first centile was rare and some individuals
were of above-average stature (case 13 was 179 cm; .97th
centile). The majority of individuals had the characteristic
prominent forehead, hypertelorism, midface hypoplasia and
depressed nasal bridge (fig 1), although exceptions were
observed (case 13; fig 1D). All but one individual with
mutations in FLNB had spatulate fingers, most specifically in
the thumb (fig 2). Conductive deafness, often with noticeable
malformation of the ossicular chain, was observed in 4 of 19
(21%) individuals.
Skeletal anomalies
Radiologically, apart from secondary abnormalities attributable
to chronic joint dislocation, the metaphyses and diaphyses of
the long bones were normal. A minority of patients (eg, case 6),
with more pronounced short stature and craniofacial anoma-
lies, exhibited distal humeral hypoplasia and thus exemplify an
overlap phenotype between Larsen syndrome and AOIII.43 In
this cohort, supernumerary carpal and tarsal ossification
centres were universally observed features in individuals for
whom relevant radiographs were available (fig 3), although
these signs may be absent in some individuals with the allelic
condition atelosteogenesis III, suggesting that they may not be
completely sensitive indicators for Larsen syndrome. Distal
phalangeal abnormalities, most severely and consistently
affecting the thumb, were similarly common (fig 3). Spinal
abnormalities were observed in 16 of 19 (84%) individuals.
Cervical kyphosis was noted in 50% of probands (fig 4), usually
on the basis of subluxation or fusion of the C2–C3–C4 vertebral
bodies. A common accompaniment was posterior vertebral arch
dysraphism, dysplasia of the vertebral laminae and hypoplasia
of the lateral processes of all cervical vertebrae. Clinical
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myelopathy, complicated by secondary ischaemic encephalo-
pathy, was observed in 3 of 20 individuals (fig 4).
Thoracolumbar scoliosis was noted in 60%, but was not
attributable to underlying vertebral anomalies on radiographs.
Molecular analysis
Heterozygotic mutations in FLNB were found in 20 probands
(table 1). Ten had arisen de novo and four segregated within
families. Most mutations were missense; there was one small
inframe deletion, 4711_4713delAAT (1571delN). Three muta-
tions were recurrent, leading to the substitutions E227K
(n = 2), G1691S (n = 6) and G1834R (n = 2). ClustalW align-
ment showed that the predicted amino acid substitutions in
Larsen syndrome occurred at sites that are highly conserved in
paralogous and orthologous forms of the protein (fig 5).
Mutations were non-randomly distributed throughout the
gene. Two clusters of mutations were evident, those in exons
2–4 encoding CH2, and those in exons 25–33 encoding filamin
repeats 13–17 (fig 6). Two patients had mutations in a region
outside these hotspots, predicting the substitutions G361S and
G363E in filamin repeat 2. One of these patients presented with
a phenotype intermediate between AOIII and Larsen syndrome
(case 6; figs 1A and 3G). There were no phenotypic differences
between patients with mutations located in the 59 compared
with the 39 hotspot of FLNB.
Intrafamilial variation for the Larsen syndrome phenotype
was studied in a large kindred segregating the recurrent
mutation 679GRA, leading to the substitution E227K, in 30
individuals over three generations (case 5). Table 2 shows the
clinical manifestations present in each member examined in this
family. Numerous clinical symptoms and signs seen in Larsen
syndrome were variable in this family. The most remarkable
example of this is III2, who has no large-joint dislocations, yet all
her children are affected to different degrees. All affected
members in the pedigree show the typical facies, with
hypertelorism absent in a minority. Cleft palate (8%) is relatively
rare in this family. Typical features such as spatulate fingers and
supernumerary carpal bones are present in the majority of the
A B C D
Figure 2 Clinical images from individuals with Larsen syndrome showing spatulate digits of (A–C) hands and (D) feet. (A) Case 15; (B) father of case 11;
(C) case 12; (D) case 8. Informed consent was obtained from all patients/guardians for publication of this figure.
A
B
C
D
E
F
Figure 1 Facial characteristics from patients with filamin B gene mutations and diagnoses of (A) Larsen syndrome/atelosteogenesis III or (B–F) Larsen syndrome.
(A) Case 6; (B) case 5; (C) affected father of case 11; (D) case 13; (E) case 11; (F) case 20. Informed consent was obtained for publication of this figure.
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affected family members. However, the first metacarpal and first
metatarsal are disproportionately broad in some subjects
(figs 7D,G,H). Some metacarpals and phalanges of affected
individuals are overtubulated (Fig 7C,D,G,H).
MCPP analysis was performed for eight members in family 5
and also for case 15 (fig 8). The MCPP profiles generated were
similar to the profiles reported previously for patients with
Larsen syndrome. 54 55 The pattern is characterised by short
metacarpals (especially the second to fifth metacarpals) and
short distal phalanges (especially the first, third and fourth).
The mean pattern variability index (sZ) was 1.36 for males and
1.35 for females (range 1.09–1.81) from family 5. A value .0.8
is indicative of a malformation syndrome.
DISCUSSION
Larsen syndrome, as originally described, comprises multiple
large-joint dislocations, midface hypoplasia and spatulate
fingers.1 Variable features included cleft palate and vertebral
defects, especially in the cervical region. Since then the
diagnosis has been applied to a wide spectrum of phenotypes
characterised by joint dislocations, including some with severe
extraskeletal manifestations and perinatal lethality. The
description of mutations in FLNB underlying autosomal
dominant Larsen syndrome, in addition to the allelic entities
spondylocarpotarsal syndrome, AOI, AOIII and boomerang
dysplasia, facilitates the study of this heterogeneous category
afresh and offers an opportunity to re-define the phenotype.
Some phenotypic features are consistently present in FLNB-
related, dominantly inherited, Larsen syndrome. Although
multiple joint dislocations, digit and craniofacial abnormalities
have previously been considered to be the defining features of
autosomal dominant Larsen syndrome,1–4 6 13 15 the presence
of other manifestations such as short stature, anterior
thoracic wall deformity (either pectus excavatum or pectus
carinatum) and spatulate fingers (most notable in the thumb)
collectively improve the diagnostic specificity for dominant
A
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G H
Figure 4 Anomalies of the cervical spine in Larsen syndrome. (A) Cervical kyphosis; (B,D) vertebral fusion and failure of fusion of the posterior neural arch
are depicted. Family 5, case IV20 demonstrating (E) multiple accessory ossification centres of the vertebral laminae; (F) deficiency of elements of the
posterior vertebral arches. Case 16 (G,H) showing cervical kyphosis complicated by cord compression and myelopathy (arrows). (A) Case 15; (B,D) case
20; (C) case 8; (E,F) family 5, case IV20; (G,H) case 16.
A B C E
D
F
G
Figure 3 Radiographic features of Larsen syndrome. (A,B) Shortening and broadening of the distal phalanges, most notable in the thumb. Supernumerary
carpal bones and a bifid calcaneal ossification centre are commonly observed. Individuals with an overlap of Larsen syndrome and atelosteogenesis type III
show more severe skeletal malformations, such as a distally tapering humerus (E). (A) Case 15, (B,E,F) case 20 (aged 1 year), (C,D) case 20 (aged 14
years), (G) case 6.
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Larsen syndrome caused by mutations in FLNB. In this series,
the only invariant feature observed in all cases of Larsen
syndrome assessed at a sufficiently advanced age was the
presence of accessory ossification centres in the carpus or tarsus
or both. Individuals who carried a pathogenic mutation in
FLNB but did not manifest one or more features previously
thought to be obligatory for the diagnosis—large-joint disloca-
tions (case 3, family 5, cases III2 and IV9), spatulate fingers
(family 5, cases III2, IV3, IV7 and III8), midface hypoplasia
(case 12) and stature below the 10th centile (cases 3, 4, 7 and
13)—were identified (table 1). Intrafamilial variability in
severity of phenotypic expression reiterates previous observa-
tions in other reported cases of Larsen syndrome.11 14 15 56
MCPP analysis indicates that autosomal dominant Larsen
syndrome is characterised by a distinctive acral patterning
defect. The mean MCPP profile for Larsen syndrome is similar
to the mean MCPP profile of males with otopalatodigital
syndrome type 1 (OPD1), a condition caused by mutations in
the paralogous gene, FLNA.55 This similarity is most pronounced
in the distal phalanges and suggests that such clinical
relatedness between these two conditions reflects commonal-
ities in their aetiopathogenesis.
Cervical spine anomalies, often leading to cervical kyphosis,
have long been recognised complications of Larsen syndrome,
but their true incidence and associated risk of myelopathy have
not been quantified. In this study, 10 of 16 individuals had
cervical vertebral anomalies, most typically fusion of C2 and C3
sometimes accompanied by subluxation of C3 on C4, and
posterior arch defects within the cervical spine. Occasionally,
anomalies can be considerably more extensive than this (fig 4).
In this series, 3 of 20 probands (15%) manifested a myelopathy.
The pronounced morbidity associated with myelopathy war-
rants spinal investigation on all individuals diagnosed with
Larsen syndrome.
In the light of the above observations, does a recessive form
of Larsen syndrome exist? These data support Mostello
et al,31 who stated that no clinical, radiographic or histological
marker separates several reports compatible with a recessively
1571delN
G1586R
V1592D
P1603L
F161C
G168S
E227K
L234V
G361S
G363E L1431R G1691S G1834R
COOHNH2
++
++
++
++
++
Figure 6 Location of predicted Larsen syndrome substitutions in filamin B. Schematic of filamin B, with two N-terminal calponin homology domains, and
repeats 1–24 with hinge regions interposed between repeats 15 and 16, and 23 and 24. Above each domain is the predicted amino acid substitutions
found in patients with Larsen syndrome. `Substitutions previously reported by Krakow et al.42
Figure 5 ClustalW alignment of homologous filamins from human, mouse, Gallus gallus, Drosophila melanogaster and Anopheles gambiae. Residues
predicted to be substituted in Larsen syndrome in filamin B (bold) and otopalatodigital syndrome spectrum disorders in filamin A (italic) are indicated. Hyp-
Fln, hypothetical filamin.
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inherited entity13 26 31 from those that describe the dominantly
transmitted phenotype, now known to be caused by mutations
in FLNB. These putative recessive entities may represent further
instances of parental germline mosaicism for a heterozygotic
FLNB mutation.18–20 The entity described in the La Re´union
Island isolate57 58 is clearly phenotypically discrete (stature –5
SD, polydactyly, advanced skeletal maturation, radioulnar
synostosis, diaphyseal bowing, metacarpophalangeal and inter-
phalangeal dislocations, lack of accessory carpal and tarsal
bones), clearly distinguishing this phenotype from autosomal
dominant Larsen syndrome due to FLNB mutations.
Nevertheless, on the basis of current evidence, a recessive form
of Larsen syndrome cannot be ruled out.5 20 26 28
Clinical and radiological analysis can distinguish bona fide
Larsen syndrome from other joint dislocation syndromes.
Desbuquois syndrome shows autosomal recessive inheritance,
advanced carpal ossification and prominent deformities of the
hands.37 59 Accessory ossification centres are associated with
the metacarpals and phalanges as opposed to the carpus.
Pseudodiastrophic dysplasia is similar to Larsen syndrome with
midface hypoplasia and clubfoot, but patients can be distin-
guished by the presence of rhizomelia, prominent dislocations
of the interphalangeal joints and most often perinatal
lethality.60 Ehlers–Danlos syndromes (arthrochalasia types;
formerly termed Ehlers–Danlos types VIIA and VIIB) are
characterised by large-joint dislocations, but are radiographi-
cally distinct from Larsen syndrome.61 Importantly, a principal
phenotypic feature in these conditions is that of hyperelastic
skin, a feature not found in Larsen syndrome.
This series reports 20 patients who were heterozygous for
mutations in FLNB. All mutations were either missense or
produced small inframe deletions.42 The predicted substitutions/
deletions were clustered, one cluster comprising exons 2–4
encoding CH2 and the other comprising exons 25–33 encoding
filamin repeats 13–17 (fig 6). The interfamilial phenotypic
variation between patients with recurring mutations was wide.
The most recurrent mutation, predicting the substitution
G1691S, was noted in six unrelated patients, with variable
consequences. These ranged from a mild phenotype comprising
dislocated knee joints, flat facies, stature .97th centile and no
cervical spine abnormalities (case 13), to severe cases with
myelopathy (case 16). Farrington-Rock et al43 described another
infant with this mutation and a distally tapering humerus,
cervical kyphosis and multiple joint dislocations indicating
overlap with AOIII. The phenotypic relatedness between Larsen
syndrome and AOIII is reinforced by reports of survival in
individuals with the AOIII entity,62 although a diagnosis of
AOIII is still appropriate in instances where incomplete
ossification of skeletal elements (such as the phalanges) or
long-bone modelling defects such as distally tapering humeri
are prominent features.
A second recurrent mutation leading to the substitution
E227K is similarly associated with variable expression. Study of
a family segregating this mutation over four generations and
having 30 affected members demonstrated that very few
phenotypic components are obligatory requirements for the
diagnosis (table 2). An unrelated case (case 4) has also been
identified as having the same 679GRA mutation. His pheno-
type is comparatively mild, comprising elbow dislocations, an
anterior thoracic wall deformity, supernumerary ossification
centres and spatulate fingers.
There are many phenotypic and genetic similarities between
the FLNB-related conditions and the OPD spectrum disorders,
which are caused by mutations in the X-linked gene, FLNA. The
FLNA-related entity bearing the most similarity to Larsen
syndrome is OPD. Multiple large-joint dislocations have not
been described in this entity, and therefore differential
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diagnosis should be problematic only in males with Larsen
syndrome who do not have this feature. The observation that
mutations cluster in FLNB in a distribution similar to that
observed in FLNA suggests parallels in the pathogenesis of
these conditions and a functional relationship between these
two filamin proteins. Some of the mutations reported to lead to
the FLNA and FLNB groups of conditions occur at exactly
homologous residues and produce identical amino acid
substitutions (fig 5). The observation that filamin A and
filamin B may heterodimerise in neuronal cells63 and are co-
expressed in the hypertrophic zone of the growth plate42 lends
weight to this hypothesis, but evidence exists that conflicts
with these data.64
Despite the observation of intense clustering of mutations
causative of Larsen syndrome, the pathogenic mechanism
leading to this disorder remains unclear. Mutations in CH2 in
the actin-binding domain may alter the regulation of the
binding of filamin to actin. However, the substitutions
identified in the filamin repeat domains do not correlate with
binding sites of known filamin B protein interactants. All
proteins known to interact with the repeat domains of filamin
B bind to the region extending from hinge 1 to the C terminus.
Whether the mutations disrupt protein interactions or facilitate
novel interactions with filamin B is unclear. Over 30 proteins
bind to filamin A65 and a similar diversity of binding partners
may exist for filamin B, some possibly participating in the
secretion of matrix components. Histological studies of the joint
capsule and tracheal cartilage of an infant with Larsen
syndrome who died of tracheobronchomalacia showed paucity
of capsular collagen and cartilage that was thinned, hypocel-
lular and contained shortened, ‘‘dysmature’’ collagen fibrils. In
another patient histology of the epiphyseal growth plate
showed disorganisation of the chondrocyte columns.31
Additionally, presenilins 1 and 2, components of the Notch
signalling pathway that is critical for somite segmentation and
the formation of the vertebrae,66 interact with filamin B.45
Disruption of presenilin–filamin B binding might be one
mechanism that leads to the vertebral anomalies observed in
Larsen syndrome (table 1, fig 4).
This work has defined autosomal dominant Larsen syndrome
as a clinically and radiographically characteristic condition with
pronounced intrafamilial and interfamilial variability. The
identification of the basis of its aetiopathogenesis as clustered
missense mutations in the cytoskeletal protein FLNB provides a
valuable adjunct to the diagnosis of this clinically highly
variable disorder.
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